鶹ýӰ

Dementia and Estrogen; Case Report on Fatality After Lecanemab; MRI-Based Brain Age

— News and commentary from the world of neurology and neuroscience

MedpageToday
Neuro Break over a computer rendering of neurons.

A nested case-control study showed that estrogen-only use in women was compared with no estrogen use. (JAMA)

Folate or was tied to a higher risk of Alzheimer's disease and changes in brain structure, but the effects were counteracted when other B vitamins were added. (The Journals of Gerontology: Series A)

Nature Communications reported the case of fatal iatrogenic cerebral beta-amyloid-related inflammation in a 79-year-old woman (Leqembi) for early Alzheimer's in the open-label extension of the CLARITY-AD trial.

Repeated blows to the head in sports or combat were identified as a potential new disease. (npj Parkinson's disease)

MRI-based brain age which patients with amyloid-negative amnestic mild cognitive impairment will convert to dementia. (Scientific Reports)

CDC data showed a gradual increase in over the past decade, with the greatest increase in people age 75 and older. (JAMA Neurology)

The Pittsburgh Post-Gazette revisited the as "type 3 diabetes."

Artificial intelligence effectively using retinal photographs. (JAMA Network Open)

An augmented reality app from otherwise healthy people who had Alzheimer's pathology. (npj Digital Medicine)

A woman with brain fog and other long COVID symptoms. (New York Times)

Are we ready for the insurance consequences of testing? (JAMA Neurology)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.